Biomarker test for Peripartum Cardiomyopathy could help reduce death after giving birth
Cardiologists have discovered biomarkers that can be used to develop a screening test to detect Peripartum Cardiomyopathy (PPCM), a life-threatening disorder that is the primary cause of mortality in pregnant women in developing countries. The results, which can lead to the immediate treatment of PPCM in new mothers and a significant reduction in mortality, were presented at Heart Failure 2014. Topics: Heart Failure (HF) (Source: ESC News and Press)
Source: ESC News and Press - May 14, 2014 Category: Cardiology Source Type: news

RELAX-AHF and PROTECT studies find targeting WHF may reduce readmissions and save lives
Heart failure is the most common reason for admission to hospital in people over 65 years old and affects millions of people each year. Research has shown that the outcomes of patients admitted with Acute Heart Failure (AHF) are dire with significant time spent in the hospital and high rates of readmissions or death within 6 months. Currently available therapies such as i.v. diuretics and vasodilators, may relieve some of the symptoms of AHF including dyspnoea, but most probably do not affect short term outcomes. Topics: Heart Failure (HF) (Source: ESC News and Press)
Source: ESC News and Press - May 14, 2014 Category: Cardiology Source Type: news

Novel device successfully treats central sleep apnoea in heart failure
A novel device implanted under the skin like a pacemaker successfully treats central sleep apnoea (CSA) in heart failure patients.  The one year results of the remede® system pilot study were revealed for the first time by lead author Professor William T. Abraham from Ohio State University. Topics: Heart Failure (HF) (Source: ESC News and Press)
Source: ESC News and Press - May 14, 2014 Category: Cardiology Source Type: news

Heart failure hospitalisation more than doubles in IBD flares
Dr Søren L. Kristensen, lead author, said: “Previous studies have shown an association between chronic inflammatory diseases (psoriasis, rheumatoid arthritis, systemic lupus erythematosus, celiac disease and IBD) and an increased incidence of venous- and arterial thrombotic disease (primarily heart attack and stroke). Researchers suggest the link is at least in part caused by inflammatory prothrombotic effects.” Topics: Heart Failure (HF) (Source: ESC News and Press)
Source: ESC News and Press - May 14, 2014 Category: Cardiology Source Type: news

Clinicians urged to consider spironolactone in HFPEF despite TOPCAT results
Clinicians have been urged to consider using spironolactone in their patients with heart failure and preserved ejection fraction (HFPEF) after a post-hoc analysis of the TOPCAT trial showed benefit in patients from the Americas.  Professor Bertram Pitt said: “We’ve had many studies showing that ACE inhibitors, angiotensin receptor blockers, beta blockers and mineralocorticoid receptor blockers reduce mortality and hospitalisations in patients with heart failure and reduced ejection fraction (HFREF). But no studies have found a benefit of these medications in HFPEF patients.” ...
Source: ESC News and Press - May 14, 2014 Category: Cardiology Source Type: news

Cardiovascular diseases rise during Greek financial crisis
Hospital admissions for cardiovascular diseases increased during the Greek financial crisis, according to two studies from Athens. Dr Alexios Samentzas said: “Greece plunged into an economic crisis in 2008 and since then there have been rises in unemployment, wage reductions and a fall in standard of living. Previous studies have shown that cardiovascular disease is more frequent during crises such as wars and natural disasters.” Topics: Heart Failure (HF) (Source: ESC News and Press)
Source: ESC News and Press - May 14, 2014 Category: Cardiology Source Type: news

RELAX-AHF: Poor diuretic response associated with worse clinical outcomes
Poor diuretic response is associated with worse in-hospital and post-discharge clinical outcomes, results of the RELAX-AHF trial reveal. The study also found that serelaxin has a neutral effect on diuretic response.  These novel data from the RELAX-AHF trial were presented by lead author Professor Adriaan A. Voors at the Heart Failure Congress 2014. Topics: Heart Failure (HF) (Source: ESC News and Press)
Source: ESC News and Press - May 14, 2014 Category: Cardiology Source Type: news

Negative iron balance predicts acute heart failure survival
Professor Ewa Jankowska, first author of the study, said: “Patients with acute heart failure have a major collapse in homeostasis. Iron is a key micronutrient that is required for the maintenance of homeostasis. Iron is needed for cellular metabolism and deficiency leads to severely impaired energy metabolism and mitochondrial dysfunction.” Topics: Heart Failure (HF) (Source: ESC News and Press)
Source: ESC News and Press - May 14, 2014 Category: Cardiology Source Type: news

Sleeping pills increase CV events in heart failure patients
Sleeping pills increase the risk of cardiovascular events in heart failure patients by 8-fold, according to research from Japan. Dr Masahiko Setoguchi said: “Sleeping problems are a frequent side effect of heart failure and it is common for patients to be prescribed sleeping pills when they are discharged from hospital. They also have other comorbidities and may be prescribed diuretics, antiplatelets, antihypertensives, anticoagulants and anti-arrhythmics.” Topics: Heart Failure (HF) (Source: ESC News and Press)
Source: ESC News and Press - May 14, 2014 Category: Cardiology Source Type: news

EACPR joins Jump In Amsterdam
Jump In is an educational programme that is so far promoted by 80 primary schools in Amsterdam. It was initiated by the Department of Social Development and Health Service of Amsterdam. The goal is to fight future obesity. Read more Topics: Cardiovascular Disease Prevention - Risk Assessment and Management (Source: ESC News and Press)
Source: ESC News and Press - May 9, 2014 Category: Cardiology Source Type: news

EACPR joins Jump In Amsterdam - watch the video
Jump In is an educational programme that is so far promoted by 80 primary schools in Amsterdam. It was initiated by the Department of Social Development and Health Service of Amsterdam. The goal is to fight future obesity. Watch the video Topics: Cardiovascular Disease Prevention - Risk Assessment and Management (Source: ESC News and Press)
Source: ESC News and Press - May 9, 2014 Category: Cardiology Source Type: news

Collective intelligence sharing to benefit daily practice will form core of EuroPCR 2014
Media alert: The cornerstone of EuroPCR 2014 will be the sharing of collective interventional wisdom. To that effect, the combination of educational scientific sessions and a new offer of digital tools pertinent to the cardiovascular interventional community will provoke and inspire discussions among participants. The meeting will be held 20–23 May 2014 at the Palais des Congrès in Paris, France.  Read more Topics: Percutaneous Cardiovascular Intervention (PCI) (Source: ESC News and Press)
Source: ESC News and Press - May 7, 2014 Category: Cardiology Source Type: news

The shape of things to come: study predicts increase in adult obesity prevalence in almost all European countries by 2030
Rates of obesity and overweight in both male and females are projected to increase in almost all countries of Europe by 2030, according to a statistical modelling study. However, the forecast rates vary throughout the 53 Euro-region countries, with projected male obesity levels ranging from 15% in the Netherlands and Belgium, to 47% in Ireland. The highest obesity prevalence in females was projected in Ireland (47%), and the lowest in Romania (10%).  Read more Topics: Cardiovascular Disease Prevention - Risk Assessment and Management (Source: ESC News and Press)
Source: ESC News and Press - May 6, 2014 Category: Cardiology Source Type: news

40 is not too old or too late to start endurance training
A study of healthy senior men has found that "relatively intensive" endurance exercise confers benefits on the heart irrespective of the age at which they began training. The benefits were evident and comparable in those who had started training before the age of 30 or after the age of 40. As a result, said the investigators, 40 is not too old to start endurance training.  Read more Topics: Cardiovascular Disease Prevention - Risk Assessment and Management, Rehabilitation and Exercise Physiology (Source: ESC News and Press)
Source: ESC News and Press - May 6, 2014 Category: Cardiology Source Type: news

Population screening for sudden cardiac death in young people is feasible with a basic screening programme
Low referral rate, but a small number of lethal pathologies likely to be detected:  Despite fears over cost, the wide-scale screening of young people to detect risk of sudden cardiac death is feasible and cost effective, according to a study presented at EuroPRevent 2014. More than 12,000 people aged between 14 and 35 were screened at a cost of £35 (40 euro) each; rates of subsequent referral for further investigation were low and considered of "a relative low additional cost" to health services.  Read more Topics: Cardiovascular Disease Prevention - Risk ...
Source: ESC News and Press - May 6, 2014 Category: Cardiology Source Type: news